Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04492488
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-05-06
First Post:
2020-07-23
Brief Title:
A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic GastricGastroesophageal Junction GEJ Cancer
Sponsor:
Shanghai Miracogen Inc
Organization:
Shanghai Miracogen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-23
First Submit QC Date:
July 27 2020
Study First Post Date:
2020-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2022-05-06
Last Update Post Date Type:
ACTUAL